MDB logo

Medicofarma Biotech SA Stock Price

WSE:MDB Community·zł31.3m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

MDB Share Price Performance

zł0
-0.31 (-100.00%)
zł0
-0.31 (-100.00%)
Price zł0

MDB Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Moderate risk with weak fundamentals.

5 Risks
0 Rewards

Medicofarma Biotech SA Key Details

zł281.4k

Revenue

zł1.4m

Cost of Revenue

-zł1.1m

Gross Profit

zł1.9m

Other Expenses

-zł3.1m

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
-0.045
-402.47%
-1,085.52%
69.6%
View Full Analysis

About MDB

Founded
2001
Employees
6
CEO
Cezary Kilczewski
WebsiteView website
medicofarmabiotech.pl

Medicofarma Biotech SA engages in the research and development of medicines, medicinal products, and biotechnology products in Poland. The company offers staff support and equipment during the early stages of development of generic pharmaceutical products and cosmetics, as well as analytical examinations. It also provides MediPAN COVID SARS-CoV-2 test, a screening test for detecting the SARS-CoV-2 virus; and real-time PCR genetic tests. The company was formerly known as Inbook Spólka Akcyjna and changed its name to Medicofarma Biotech SA in February 2021. Medicofarma Biotech SA was founded in 2001 and is headquartered in Warsaw, Poland. The company operates as a subsidiary of Vitama Spolka Akcyjna.

Recent MDB News & Updates

Recent updates

No updates